Response and remission rates after 5 weeks of treatment in 40 depressed patients (sample 2) treated with either reboxetine (n = 20) or mirtazapine (n = 20) [33]. Patients are subdivided into COR peak

NIAID Data Ecosystem50

Primary Outcomes.

资源简介：

相关数据集